coumarin has been researched along with Ischemic Attack, Transient in 2 studies
2H-chromen-2-one: coumarin derivative
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with ischemic stroke or transient ischemic attack presumably related to patent foramen ovale (PFO) are at risk for recurrent cerebrovascular events." | 1.38 | Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. ( Geister, L; Jüni, P; Kalesan, B; Mattle, HP; Meier, B; Mono, ML; Nedeltchev, K; Praz, F; Räber, L; Wahl, A; Windecker, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wahl, A | 1 |
| Jüni, P | 1 |
| Mono, ML | 1 |
| Kalesan, B | 1 |
| Praz, F | 1 |
| Geister, L | 1 |
| Räber, L | 1 |
| Nedeltchev, K | 1 |
| Mattle, HP | 1 |
| Windecker, S | 1 |
| Meier, B | 1 |
| Schipper, JP | 1 |
2 other studies available for coumarin and Ischemic Attack, Transient
| Article | Year |
|---|---|
Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
Topics: Adult; Anticoagulants; Cardiac Catheterization; Cardiovascular Diseases; Case-Control Studies; Couma | 2012 |
[Consensus on antithrombotic prophylaxis of vascular events in patients with manifested atherosclerotic vascular disease].
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Cou | 1998 |